Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 20 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-02-28 Shkreli Martin Chief Executive Officer Purchase +43,000 $18.67 $803K 2,880,222
2014-02-24 Shkreli Martin Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +200,000 200,000
2014-02-24 Shkreli Martin Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000
2014-02-24 Shkreli Martin Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000
2014-02-24 Plotkin Horacio Chief Medical Officer Grant or award +100,000 102,200
2014-02-24 PANOFF MARC L Chief Financial Officer Grant or award +100,000 221,100
2014-02-21 Shkreli Martin Chief Executive Officer Purchase +100 $17.20 $2K 2,837,222
2014-02-21 Shkreli Martin Chief Executive Officer Purchase +1,600 $17.56 $28K 2,837,122
2014-02-14 Shkreli Martin Chief Executive Officer Purchase +3,500 $14.60 $51K 2,835,522
2014-02-06 Shkreli Martin Chief Executive Officer Purchase +2,000 $9.92 $20K 2,832,022
2014-01-14 Shkreli Martin Chief Executive Officer Purchase +8,000 $10.84 $87K 2,830,022
2013-09-12 Shkreli Martin Chief Executive Officer Purchase +5,556 $4.50 $25K 2,665,596
2013-09-12 Shkreli Martin Chief Executive Officer Other acquisition +2,904 2,668,500
2013-09-12 Shkreli Martin Chief Executive Officer Purchase · Common Stock Purchase Warrants +2,778 2,778

Page 59 of 59 · 1,174 trades